Clinical trial
Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus…
NCT00423488 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00423488 |
|---|---|
| Title | Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED) |
| Official title | A Multicenter, Randomized, Parallel-Groups, Double-Blind Placebo Controlled Study Comparing the Efficacy, Safety, and Tolerability of Co-administration of Ezetimibe 10 mg With Ongoing Treatment With Simvastatin 20 mg Versus Doubling the Dose of Simvastatin in Subjects With Primary… |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Diabetes Mellitus, Type 2, Coronary Disease |
| Intervention type | Drug |
| Interventions | Ezetimibe 10 mg, Simvastatin 20 mg, Ezetimibe Placebo, Simvastatin Placebo |
| Enrollment | 93 |
| Start date | Jul 12, 2005 |
| Primary completion | Feb 16, 2007 |
| Completion | Feb 16, 2007 |
| First posted | Jan 18, 2007 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: